Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 6
1991 13
1992 8
1993 8
1994 10
1995 9
1996 5
1997 12
1998 5
1999 10
2000 8
2001 6
2002 15
2003 6
2004 9
2005 15
2006 19
2007 17
2008 24
2009 19
2010 22
2011 40
2012 30
2013 27
2014 26
2015 36
2016 35
2017 43
2018 45
2019 54
2020 60
2021 73
2022 73
2023 61
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

715 results

Results by year

Filters applied: . Clear all
Page 1
Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07.
Kakeji Y, Yoshida K, Kodera Y, Kochi M, Sano T, Ichikawa W, Lee SW, Shibahara K, Shikano T, Kataoka M, Ishiguro A, Ojima H, Sakai Y, Musha N, Takase T, Kimura T, Takeuchi M, Fujii M. Kakeji Y, et al. Gastric Cancer. 2022 Jan;25(1):188-196. doi: 10.1007/s10120-021-01224-2. Epub 2021 Aug 5. Gastric Cancer. 2022. PMID: 34351555 Clinical Trial.
Real-world Evaluation of the Efficacy of Neoadjuvant DCF Over CF in Esophageal Squamous Cell Carcinoma: Propensity Score-matched Analysis From 85 Authorized Institutes for Esophageal Cancer in Japan.
Matsuda S, Kitagawa Y, Takemura R, Okui J, Okamura A, Kawakubo H, Muto M, Kakeji Y, Takeuchi H, Watanabe M, Doki Y. Matsuda S, et al. Among authors: kakeji y. Ann Surg. 2023 Jul 1;278(1):e35-e42. doi: 10.1097/SLA.0000000000005533. Epub 2022 Jul 15. Ann Surg. 2023. PMID: 35837977
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial.
Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, Nagao N, Takahashi M, Takagane A, Watanabe T, Kaji M, Okitsu H, Nomura T, Matsui T, Yoshikawa T, Matsuyama J, Yamada M, Ito S, Takeuchi M, Fujii M. Yoshida K, et al. Among authors: kakeji y. J Clin Oncol. 2019 May 20;37(15):1296-1304. doi: 10.1200/JCO.18.01138. Epub 2019 Mar 29. J Clin Oncol. 2019. PMID: 30925125 Free PMC article. Clinical Trial.
Surgery: To what extent can we operate?
Kakeji Y. Kakeji Y. Ann Gastroenterol Surg. 2018 Oct 25;2(6):398-399. doi: 10.1002/ags3.12219. eCollection 2018 Nov. Ann Gastroenterol Surg. 2018. PMID: 30460341 Free PMC article. No abstract available.
Evolution of treatment strategies for gastric cancer.
Kakeji Y. Kakeji Y. Ann Gastroenterol Surg. 2023 Aug 10;7(5):694-695. doi: 10.1002/ags3.12729. eCollection 2023 Sep. Ann Gastroenterol Surg. 2023. PMID: 37663956 Free PMC article. No abstract available.
Application of iNKT Cell-targeted Active Immunotherapy in Cancer Treatment.
Yamashita K, Arimoto A, Nishi M, Tanaka T, Fujita M, Fukuoka E, Sugita Y, Nakagawa A, Hasegawa H, Suzuki S, Kakeji Y. Yamashita K, et al. Among authors: kakeji y. Anticancer Res. 2018 Jul;38(7):4233-4239. doi: 10.21873/anticanres.12719. Anticancer Res. 2018. PMID: 29970556 Review.
Recent updates in the surgical treatment of colorectal cancer.
Matsuda T, Yamashita K, Hasegawa H, Oshikiri T, Hosono M, Higashino N, Yamamoto M, Matsuda Y, Kanaji S, Nakamura T, Suzuki S, Sumi Y, Kakeji Y. Matsuda T, et al. Among authors: kakeji y. Ann Gastroenterol Surg. 2018 Feb 15;2(2):129-136. doi: 10.1002/ags3.12061. eCollection 2018 Mar. Ann Gastroenterol Surg. 2018. PMID: 29863145 Free PMC article. Review.
715 results